RxDoctor Payments Data

David Azouz

Plastic Surgery · Dallas, TXNPI 1528139110

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $7,300 of the $9,448 with a category attached, or 77.3%. Covidien LP accounts for 70.5% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2020 at $6,651 and has fallen 85.3% since, to $980 in 2025.

$9,448in general payments, 2019–2025

Across 47 payments — averaging $201.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Covidien LP$7K
  • AbbVie$886
  • Bard Peripheral Vascular, Inc.$700
  • Axogen$209
  • Medtronic$200
  • Integra Lifesciences Corporation$141
  • plus $649 from 15 others

What the payments were for

  • Consulting fees$7758%
  • Speaking & faculty fees$7,30077%
  • Food & beverage$1,37315%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,448 in reported general payments places this provider in the 80th percentile of 337 plastic surgery providers in Texas.

See all plastic surgery providers in Texas →

Other plastic surgery in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →